Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 21.39%168.51M | -28.18%225.81M | -19.75%138.82M | 0.80%314.43M | -5.92%172.97M | -31.61%311.95M | -17.68%183.85M | -7.46%456.13M | 0.16%223.34M | -31.68%492.88M |
| Operating income | 21.39%168.51M | -28.18%225.81M | -19.75%138.82M | 0.80%314.43M | -5.92%172.97M | -31.61%311.95M | -17.68%183.85M | -7.46%456.13M | 0.16%223.34M | -31.68%492.88M |
| Cost of sales | 14.54%-93.65M | 30.48%-164.63M | 10.76%-109.59M | -7.13%-236.81M | -1.21%-122.8M | 16.64%-221.06M | 9.91%-121.34M | 4.53%-265.18M | -11.07%-134.69M | 12.42%-277.74M |
| Operating expenses | 14.54%-93.65M | 30.48%-164.63M | 10.76%-109.59M | -7.13%-236.81M | -1.21%-122.8M | 16.64%-221.06M | 9.91%-121.34M | 4.53%-265.18M | -11.07%-134.69M | 12.42%-277.74M |
| Gross profit | 156.11%74.86M | -21.17%61.18M | -41.74%29.23M | -14.60%77.61M | -19.74%50.17M | -52.41%90.88M | -29.48%62.51M | -11.24%190.95M | -12.85%88.65M | -46.79%215.14M |
| Selling expenses | 24.57%-14.77M | -25.36%-63M | -16.70%-19.58M | -68.84%-50.25M | -36.95%-16.78M | 44.34%-29.77M | 57.70%-12.25M | 48.99%-53.48M | 26.47%-28.96M | 7.08%-104.84M |
| Administrative expenses | 8.80%-29.69M | 13.67%-76.81M | 13.00%-32.56M | -18.71%-88.97M | -9.40%-37.42M | -3.57%-74.95M | -10.99%-34.2M | -6.77%-72.37M | 6.93%-30.82M | 26.70%-67.78M |
| Impairment and provision | -234.64%-3.89M | -29.19%-47.73M | 127.77%2.89M | 58.31%-36.94M | -35.23%-10.4M | -63.39%-88.62M | 71.42%-7.69M | -438.72%-54.24M | -166.57%-26.89M | 119.25%16.01M |
| -Other impairment is provision | -234.64%-3.89M | -29.19%-47.73M | 127.77%2.89M | 58.31%-36.94M | -35.23%-10.4M | -63.39%-88.62M | 71.42%-7.69M | -438.72%-54.24M | -166.57%-26.89M | 119.25%16.01M |
| Special items of operating profit | -68.05%11.83M | 146.13%37.33M | 425.90%37.04M | -17.84%15.17M | -42.71%7.04M | -30.31%18.46M | -31.88%12.29M | 18.23%26.49M | 71.31%18.05M | 33.29%22.41M |
| Operating profit | 125.28%38.35M | -6.76%-89.02M | 330.79%17.02M | 0.71%-83.39M | -135.69%-7.38M | -324.76%-83.98M | 3.20%20.66M | -53.83%37.37M | -32.49%20.02M | -38.99%80.94M |
| Financing income | 114.95%759K | ---- | ---5.08M | ---- | ---- | ---- | -97.85%746K | ---- | 7.72%34.73M | ---44.12M |
| Financing cost | ---- | -485.51%-12.4M | ---- | 13.16%-2.12M | --1.03M | -111.90%-2.44M | ---- | --20.5M | ---- | ---- |
| Special items of earning before tax | -32.44%-2.73M | -80.19%-471.04M | 14.44%-2.06M | -2,344.44%-261.41M | 68.75%-2.41M | -133,775.00%-10.69M | -586.21%-7.71M | 100.38%8K | 29.62%-1.12M | 99.76%-2.1M |
| Earning before tax | 268.07%36.37M | -65.02%-572.46M | 212.89%9.88M | -257.21%-346.91M | -163.92%-8.75M | -267.81%-97.12M | -74.46%13.7M | 66.67%57.87M | -11.07%53.62M | 104.85%34.72M |
| Tax | 78.46%-182K | 75.06%-1.49M | 82.07%-845K | -11.31%-5.95M | 19.77%-4.71M | 51.01%-5.35M | 34.88%-5.87M | 38.67%-10.92M | 8.90%-9.02M | 37.56%-17.81M |
| After-tax profit from continuing operations | 300.48%36.19M | -62.65%-573.95M | 167.10%9.04M | -244.37%-352.87M | -272.19%-13.47M | -318.23%-102.47M | -82.47%7.82M | 177.54%46.95M | -11.50%44.6M | 102.27%16.92M |
| Earning after tax | 300.48%36.19M | -62.65%-573.95M | 167.10%9.04M | -244.37%-352.87M | -272.19%-13.47M | -318.23%-102.47M | -82.47%7.82M | 177.54%46.95M | -11.50%44.6M | 102.27%16.92M |
| Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---55K |
| Profit attributable to shareholders | 300.48%36.19M | -62.65%-573.95M | 167.10%9.04M | -244.37%-352.87M | -272.19%-13.47M | -318.23%-102.47M | -82.47%7.82M | 176.64%46.95M | -11.50%44.6M | 102.28%16.97M |
| Basic earnings per share | 276.19%0.0079 | -44.04%-0.1292 | 160.00%0.0021 | -143.09%-0.0897 | -216.67%-0.0035 | -300.54%-0.0369 | -83.15%0.003 | 170.59%0.0184 | -11.44%0.0178 | 102.28%0.0068 |
| Diluted earnings per share | 276.19%0.0079 | -44.04%-0.1292 | 160.00%0.0021 | -143.09%-0.0897 | -216.67%-0.0035 | -300.54%-0.0369 | -82.25%0.003 | 170.59%0.0184 | -15.92%0.0169 | 102.28%0.0068 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Guowei Certified Public Accountants Co., Ltd. | -- | National Health Accounting Firm Limited | -- | Guowei Certified Public Accountants Co., Ltd. | -- | National Health Accounting Firm Limited | -- | National Health Accounting Firm Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.